Gaganjit Kaur: Nesfatin-1 as a Neuroprotective Target in Hyperhomocysteinemia-Induced VCID
Gaganjit Kaur, Associate Professor at Maharaja Agrasen University, shared a post on LinkedIn, about a recent article by Gaganjit Kaur et al., published in International Journal of Drug Delivery Technology adding:
“L-Methionine 1.7 g/kg; for 8 weeks, orally, induced hyperhomocysteinemia, and consequent VCID.
Nesfatin-1 is a neuropeptide, highly expressed in brain.
Nesfatin-1 is involved in appetite regulation, mitochondrial biogenesis and energy production, neuroprotection.
In addition Nesfatin-1 exhibits potent anti-neuroinflammatory, antioxidant and antiapoptotic effect․”
Tiltle: Nesfatin-1 Ameliorated Cognitive Functions In L-Methionine-Induced Vascular Cognitive Impairment and Dementia By Restoring Brain Mitochondrial Activity
Authors: Gaganjit Kaur, Sushma Devi, Manish Shukla, Manish Kumar, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, Maharaja Agrasen School of Pharmacy, Maharaja Agrasen University, Baddi, Solan, Himachal Pradesh, India
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention